iGlarLixi CGM Study in Chinese T2D Individuals After OADs

Clinical trial NCT06671587 · RECRUITING

Trial details

NCT number: NCT06671587
Sponsor: Sanofi
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Type 2 Diabetes (T2D)

Start date: 2024-12-10
Primary completion: 2026-09-18
Enrollment: 678

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.